CLC Number:
| [1] Korf BR. Diagnosis and management of neurofibromatosis type1[J]. Curr Neurol Neurosci Rep, 2001, 1(2):162-167. [2] Duman O, Ozdemb S, Turkkahraman D, et al. Bone metabolism markers and bone mineral density in children with neurofibromatosis type1[J]. Brain Dev, 2008, 30(9):584-588. [3] Vitale MG, Guha A, Skaggs DL. Orthopaedic manifestations of neurofibromatosis in children:an update[J]. Clin Orthop RelatRes, 2002, 401:107-118. [4] Roberts L. Down to the wire for the NF gene[J]. Science, 1990, 249(4966):236-238. [5] Patel NP, Mhatre AN, Lalwani AK. Molecularpathogenesis of skull base tumors[J]. Otol Neurotol, 2004, 25(4):636-643. [6] Yohay KH. The genetic and molecular pathogenesis of NF1 and NF2[J]. Senmin Pediator Neurol, 2006, 13(1):21-26. [7] 齐向东,王伟民,张斌,等.数字化辅助技术在神经纤维瘤手术方案选择中的应用[J].组织工程与重建外科杂志,2014,10(1):51-53. [8] Kim S, Roh S, Lee N, et al. Radiofrequency ablation and excision of multiple cutaneous lesions in neurofibromatosis type1[J]. Arch Facial Plast S, 2013, 40(1):57-61. [9] Maruta H. Effective neurofibromatosis therapeutics blocking theoncogenic kinase PAK1[J]. Drug Discov Ther, 2011, 5(6):266-278. |
| No related articles found! |
| Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Full text 213
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Abstract 846
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Cited |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Shared | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Discussed | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
||
